Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
128 participants
INTERVENTIONAL
2012-04-02
2013-10-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MOTIONPOD (TM) Validation and Calibration Study
NCT01317732
Clinical Validation of a Mobility Monitor to Measure and Predict Health Outcomes
NCT04911231
Accuracy Activity Monitors for Inhospital Activity Monitoring of Geriatric Patients
NCT04865627
Digital Assessment of Real-World Walking Activity in Pulmonary Hypertension: A Prospective Multicenter Trial
NCT07137260
Validity of an Actigraph Accelerometer Following Critical Illness
NCT03295630
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MotionPod Validation
Medical device validation
MOTIONPODTM device validation
MOTIONPODTM validation in free-living conditions using gold standards, including the DLW method
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MOTIONPODTM device validation
MOTIONPODTM validation in free-living conditions using gold standards, including the DLW method
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age : 18 to 75 years
* Patients or healthy volunteers
* 40 obese subjects (BMI ≥ 30 kg/m2), 40 non-obese (BMI \<30 kg/m2) and active (PA level evaluated by the RPAQ questionnaire) subjects, 40 non-obese and sedentary subjects
* Absence of cardiac rate disorders
Exclusion Criteria
* Subjects with a pathology restricting the walking distance (confinement, distance \<200 meters)
* Subjects with implants (Pacemaker, cardiac implant or another active implant)
* Claustrophobic subjects (for subjects participating to "doubly labelled water" protocol)
* Drug use that could affect energy expenditure
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre de Recherche en Nutrition Humaine Rhône-Alpes - Centre hospitalier Lyon Sud
Pierre-Bénite, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011.702
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.